White & Case advises GHD on sale of Sangro to private equity investor Axcel
1 min read
Global law firm White & Case LLP has advised GHD GesundHeits GmbH (GHD), a Nordic Capital portfolio company, on the sale of its sangro medical services division (Sangro) to private equity investor Axcel.
As part of the transaction, GHD will divest sangro medical service GmbH, a leading distributor and logistics provider for homecare products and medical care, and will further sharpen its focus on its core homecare business.
The transaction is expected to close in the first half of 2026.
The White & Case team in Germany which advised on the transaction was led by partners Stefan Koch and Jan Ole Eichstädt and included partners Mathias Bogusch, Tim Bracksiek and Sebastian Stütze and Thilo Wienke, local partners Alisa Preissler and Markus Fischer, counsel Katrin Helle, associates Eva Shaw, Michael Grambow, Marc Hering, Alexander von der Wense, Justus Redeker and Daniel Stübbe and transaction lawyer Stella Hülsenbeck.
Press contact
For more information please speak to your local media contact.
